Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jisheng Liu (Long Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 52

Top Venues

Signal transduction and targeted therapy

Molecular biomedicine

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Nature communications

Leiden University Medical Center (LUMC)

Tsinghua University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center (LUMC)

Netherlands

Researcher

Education History

Tsinghua University

China

PHD

Publications

Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Peng Su, Fangfang Zhou, Jisheng Liu
Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium. Signal transduction and targeted therapy 8 (1) (2023)
Yifei Tu, Fangfang Zhou, Jisheng Liu
SIK3-HDAC4 signaling pathway: the switch for transition between sleep and wakefulness. Molecular biomedicine 4 (1) (2023)
Xin Niu, Fangfang Zhou, Jisheng Liu
Microglia regulate the health of central nervous system through myelin. Molecular biomedicine 4 (1) (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Ran Li, Jing Zou, Dongling Pei, Ting Pan, Bing Yang, Xianzhi Liu, Yan Chen, Fangfang Zhou, Jisheng Liu
Deciphering dynamic changes of the aging transcriptome with COVID-19 progression and convalescence in the human blood. Signal transduction and targeted therapy 8 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Xin Niu, Fangfang Zhou, Jisheng Liu
Microglia regulate the health of central nervous system through myelin. Molecular biomedicine 4 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Tong Dai, Lei Zhang, Yu Ran, Meirong Zhang, Bing Yang, Huasong Lu, Shixian Lin, Jisheng Liu, Fangfang Zhou
MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation. Nature structural & molecular biology (2023)
Xin Niu, Fangfang Zhou, Jisheng Liu
Microglia regulate the health of central nervous system through myelin. Molecular biomedicine 4 (1) (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Xin Niu, Lei Zhang, Yuchen Wu, Zhi Zong, Bin Wang, Jisheng Liu, Jisheng Liu, Fangfang Zhou
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. MedComm 4 (2) (2023)
Zhengyu Gao, Bin Wang, Jisheng Liu
Activated STING: an ion channel to trigger non-interferon-related functions. Signal transduction and targeted therapy 8 (1) (2023)
Qiqing Yang, Bin Wang, Qinghui Zheng, Heyu Li, Xuli Meng, Fangfang Zhou, Jisheng Liu
A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Jiang Ren, Peng Yu, Sijia Liu, Ran Li, Xin Niu, Yan Chen, Zhenyu Zhang, Fangfang Zhou, Jisheng Liu
Deubiquitylating Enzymes in Cancer and Immunity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yongqiang Wang, Jisheng Liu, Fangfang Zhou
The role of TIA1 and TIAL1 in germinal center B cell function and survival. Cellular & molecular immunology (2023)
Xin Niu, Lei Zhang, Yuchen Wu, Zhi Zong, Bin Wang, Jisheng Liu, Jisheng Liu, Fangfang Zhou
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. MedComm 4 (2) (2023)
Peng Su, Fangfang Zhou, Jisheng Liu
Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium. Signal transduction and targeted therapy 8 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Wenlong Ding, Chao Liu, Yulin Chen, Jiayu Gu, Chengzhu Fang, Linzhen Hu, Jisheng Liu, Ying Yuan, Xin-Hua Feng, Shixian Lin
Computational design and genetic incorporation of lipidation mimics in living cells. Nature chemical biology (2023)
Sijia Liu, Jiang Ren, Jisheng Liu
Ras homolog family member J (RHOJ): a key regulator of chemoresistance associated with epithelial-mesenchymal transition. Signal transduction and targeted therapy 8 (1) (2023)
Ran Li, Jing Zou, Dongling Pei, Ting Pan, Bing Yang, Xianzhi Liu, Yan Chen, Fangfang Zhou, Jisheng Liu
Deciphering dynamic changes of the aging transcriptome with COVID-19 progression and convalescence in the human blood. Signal transduction and targeted therapy 8 (1) (2023)
Feng Xie, Xiaoxue Zhou, Heyu Li, Peng Su, Sijia Liu, Ran Li, Jing Zou, Xiang Wei, Chen Pan, Zhengkui Zhang, Min Zheng, Zhuang Liu, Xuli Meng, Huib Ovaa, Peter Ten Dijke, Fangfang Zhou, Jisheng Liu
USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII. The EMBO journal 41 (16) (2022)
Bin Wang, Lei Zhang, Yongqiang Wang, Tong Dai, Ziran Qin, Fangfang Zhou, Jisheng Liu
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy 7 (1) (2022)
Yongsheng Huang, Sijia Liu, Mengjie Shan, Sophie C Hagenaars, Wilma E Mesker, Danielle Cohen, Lin Wang, Zhi Zheng, Peter Devilee, Rob A E M Tollenaar, Zhangfu Li, Yongmei Song, Jisheng Liu, Dan Li, Peter Ten Dijke
RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis. Cell death & disease 13 (1) (2022)
Xiang Wei, Feng Xie, Xiaoxue Zhou, Yuchen Wu, Haiyan Yan, Ting Liu, Jun Huang, Fangwei Wang, Fangfang Zhou, Jisheng Liu
Role of pyroptosis in inflammation and cancer. Cellular & molecular immunology 19 (9) (2022)
Tong Yao, Shuai Wang, Jisheng Liu, Johnson Yiu-Nam Lau, Fangfang Zhou
Opsonizing antibodies mediated SARS-CoV-2 entry into monocytes leads to inflammation. MedComm - Future medicine 1 (1) (2022)
Yifan Xie, Feng Xie, Xiaoxue Zhou, Lei Zhang, Bing Yang, Jun Huang, Fangwei Wang, Haiyan Yan, Linghui Zeng, Jisheng Liu, Fangfang Zhou
Microbiota in Tumors: From Understanding to Application. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (21) (2022)
Feng Xie, Xiaoxue Zhou, Peng Su, Heyu Li, Yifei Tu, Jinjin Du, Chen Pan, Xiang Wei, Min Zheng, Ke Jin, Liyan Miao, Chao Wang, Xuli Meng, Hans van Dam, Peter Ten Dijke, Jisheng Liu, Fangfang Zhou
Breast cancer cell-derived extracellular vesicles promote CD8 + T cell exhaustion via TGF-β type II receptor signaling. Nature communications 13 (1) (2022)
Jizhong Guan, Jisheng Liu, Fangfang Zhou
PI3K-PANK4: a new target for de novo synthesis of coenzyme A. Molecular biomedicine 3 (1) (2022)
Jingxian Li, Mengdi Zhang, Weirui Ma, Bing Yang, Huasong Lu, Fangfang Zhou, Jisheng Liu
Post-translational modifications in liquid-liquid phase separation: a comprehensive review. Molecular biomedicine 3 (1) (2022)
Xiuwu Fang, Jisheng Liu
ZBP1 contributes to interferonopathies caused by impaired ADAR1 function. Molecular biomedicine 3 (1) (2022)
Ziran Qin, Xiuwu Fang, Wenhuan Sun, Zhenyu Ma, Tong Dai, Shuai Wang, Zhi Zong, Huizhe Huang, Heng Ru, Huasong Lu, Bing Yang, Shixian Lin, Fangfang Zhou, Jisheng Liu
Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity. Nature immunology 23 (8) (2022)
Lei Zhao, Xiaoxue Zhou, Feng Xie, Lei Zhang, Haiyan Yan, Jun Huang, Chong Zhang, Fangfang Zhou, Jun Chen, Jisheng Liu
Ferroptosis in cancer and cancer immunotherapy. Cancer communications (London, England) 42 (2) (2022)
Feng Xie, Peng Su, Ting Pan, Xiaoxue Zhou, Heyu Li, Huizhe Huang, Aijun Wang, Fangwei Wang, Jun Huang, Haiyan Yan, Linghui Zeng, Jisheng Liu, Fangfang Zhou
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Advanced materials (Deerfield Beach, Fla.) (2021)
Shuai Wang, Tong Dai, Ziran Qin, Ting Pan, Feng Chu, Lingfeng Lou, Jisheng Liu, Bing Yang, Huizhe Huang, Huasong Lu, Fangfang Zhou
Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nature cell biology 23 (7) (2021)
Ke Jin, Fangfang Zhou, Jisheng Liu
Cancer Environment Immunotherapy: targeting TGF-β finds its way towards tissue healing and vasculature remodeling. Signal transduction and targeted therapy 6 (1) (2021)
Bin Wang, Lei Zhang, Tong Dai, Ziran Qin, Huasong Lu, Jisheng Liu, Fangfang Zhou
Liquid-liquid phase separation in human health and diseases. Signal transduction and targeted therapy 6 (1) (2021)
Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Ling-Hui Zeng, Jun Huang, Haiyan Yan, Jisheng Liu, Fangfang Zhou
The way of SARS-CoV-2 vaccine development: success and challenges. Signal transduction and targeted therapy 6 (1) (2021)
Xin-Hua Feng, Jianhua Deng, Hanchenxi Zhang, Xinran Li, Shuchen Gu, Mingjie Zheng, Mei Tang, Yezhang Zhu, Xin Lin, Jianping Jin, Jisheng Liu, Jun Huang, Jian Zou, Zong-Ping Xia, Ping-Long Xu, Li Shen, Jonathan C Zhao
HSPA13 facilitates NF-κB-mediated transcription and attenuates cell death responses in TNFα signaling. Science advances 7 (41) (2021)
Yao Fan, Jisheng Liu, Fangfang Zhou
cGAS-like receptors: new RNA sensors in Drosophila. Signal transduction and targeted therapy 6 (1) (2021)
Zhangliang Cheng, Tong Dai, Xuelin He, Zhengkui Zhang, Feng Xie, Shuai Wang, Jisheng Liu, Fangfang Zhou
The interactions between cGAS-STING pathway and pathogens. Signal transduction and targeted therapy 5 (1) (2020)
Ke Jin, Jisheng Liu, Fangfang Zhou
An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering. Signal transduction and targeted therapy 5 (1) (2020)
Yetian Dong, Tong Dai, Yujun Wei, Jisheng Liu, Min Zheng, Fangfang Zhou
A systematic review of SARS-CoV-2 vaccine candidates. Signal transduction and targeted therapy 5 (1) (2020)
Feng Xie, Xiaoxue Zhou, Meiyu Fang, Heyu Li, Peng Su, Yifei Tu, Jisheng Liu, Fangfang Zhou
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 6 (24) (2019)
Pei-Jie Zhou, Xiao Wang, Na An, Lianzi Wei, Jisheng Liu, Xingxu Huang, Helen He Zhu, Yu-Xiang Fang, Wei-Qiang Gao
Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes. Oncogene 38 (12) (2018)
Liang Gao, Lin Wang, Tong Dai, Ke Jin, Zhengkui Zhang, Shuai Wang, Feng Xie, Pengfei Fang, Bing Yang, Huizhe Huang, Hans van Dam, Fangfang Zhou, Jisheng Liu
Tumor-derived exosomes antagonize innate antiviral immunity. Nature immunology 19 (3) (2018)
Zhengjun Gao, Yiyuan Li, Fei Wang, Tao Huang, Keqi Fan, Yu Zhang, Jiangyan Zhong, Qian Cao, Tong Chao, Junling Jia, Shuo Yang, Jisheng Liu, Yichuan Xiao, Ji-Yong Zhou, Xin-Hua Feng, Jin Jin
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability. Nature communications 8 (1) (2017)
Fangfang Zhou, Feng Xie, Ke Jin, Zhengkui Zhang, Marcello Clerici, Rui Gao, Maarten van Dinther, Titia K Sixma, Huizhe Huang, Jisheng Liu, Peter Ten Dijke
USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling. The EMBO journal 36 (11) (2017)
Zhengkui Zhang, Yao Fan, Feng Xie, Hang Zhou, Ke Jin, Li Shao, Wenhao Shi, Pengfei Fang, Bing Yang, Hans van Dam, Peter Ten Dijke, Xiaofeng Zheng, Xiaohua Yan, Junling Jia, Min Zheng, Jin Jin, Chen Ding, Sheng Ye, Fangfang Zhou, Jisheng Liu
Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nature communications 8 (1) (2017)

Jisheng Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Long Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Jisheng Liu (Long Zhang)